Ocean Power Technologies, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Ocean Power Technologies, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $5.86M | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $5.53M | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | $2.73M | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | $1.76M | Jul 28, 2023 |
| FY2020 | Apr 30, 2020 | $1.70M | Jun 29, 2020 |
| FY2020 | Apr 30, 2019 | $600.0K | Jun 29, 2020 |
| FY2019 | Apr 30, 2018 | $511.0K | Jul 22, 2019 |
| FY2018 | Apr 30, 2017 | $843.0K | Jul 17, 2018 |
| FY2017 | Apr 30, 2016 | $705.0K | Jul 14, 2017 |
| FY2016 | Apr 30, 2015 | $4.11M | Jul 15, 2016 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Apr 30, 2022 | $1.76M | Jul 13, 2022 |
| FY2022 | Apr 30, 2021 | $1.21M | Jul 13, 2022 |
| FY2021 | Apr 30, 2020 | $1.68M | Jul 19, 2021 |
| FY2020 | Apr 30, 2019 | $632.0K | Jun 29, 2020 |
| FY2019 | Apr 30, 2018 | $511.0K | Jul 22, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $1.66M | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $2.83M | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | $236.0K | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | ($101.0K) | Jul 28, 2023 |
| FY2022 | Apr 30, 2021 | ($1.07M) | Jul 13, 2022 |
| FY2021 | Apr 30, 2020 | ($105.0K) | Jul 19, 2021 |
| FY2020 | Apr 30, 2019 | ($671.0K) | Jun 29, 2020 |
| FY2019 | Apr 30, 2018 | ($252.0K) | Jul 22, 2019 |
| FY2018 | Apr 30, 2017 | ($95.0K) | Jul 17, 2018 |
| FY2017 | Apr 30, 2016 | $37.0K | Jul 14, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($21.51M) | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | ($27.48M) | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | ($26.33M) | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | ($18.87M) | Jul 28, 2023 |
| FY2022 | Apr 30, 2021 | ($14.76M) | Jul 13, 2022 |
| FY2021 | Apr 30, 2020 | ($10.35M) | Jul 19, 2021 |
| FY2020 | Apr 30, 2019 | ($12.25M) | Jun 29, 2020 |
| FY2019 | Apr 30, 2018 | ($10.16M) | Jul 22, 2019 |
| FY2018 | Apr 30, 2017 | ($9.49M) | Jul 17, 2018 |
| FY2017 | Apr 30, 2016 | ($13.13M) | Jul 14, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($21.69M) | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | ($29.33M) | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | ($29.22M) | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | ($21.55M) | Jul 28, 2023 |
| FY2022 | Apr 30, 2021 | ($13.59M) | Jul 13, 2022 |
| FY2021 | Apr 30, 2020 | ($11.37M) | Jul 19, 2021 |
| FY2020 | Apr 30, 2019 | ($13.27M) | Jun 29, 2020 |
| FY2019 | Apr 30, 2018 | ($11.56M) | Jul 22, 2019 |
| FY2018 | Apr 30, 2017 | ($11.69M) | Jul 17, 2018 |
| FY2017 | Apr 30, 2016 | ($14.86M) | Jul 14, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $3.60M | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $7.70M | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | $10.00M | Jul 25, 2024 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Apr 30, 2021 | $7.77M | Jul 19, 2021 |
| FY2021 | Apr 30, 2020 | $6.92M | Jul 19, 2021 |
| FY2020 | Apr 30, 2019 | $7.62M | Jun 29, 2020 |
| FY2019 | Apr 30, 2018 | $6.99M | Jul 22, 2019 |
| FY2018 | Apr 30, 2017 | $6.56M | Jul 17, 2018 |
| FY2017 | Apr 30, 2016 | $6.75M | Jul 14, 2017 |
| FY2016 | Apr 30, 2015 | $9.57M | Jul 15, 2016 |
| FY2015 | Apr 30, 2014 | $9.36M | Jul 6, 2015 |
| FY2014 | Apr 30, 2013 | $9.13M | Jul 29, 2014 |
| FY2013 | Apr 30, 2012 | $8.27M | Jul 12, 2013 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($18.63M) | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | ($29.76M) | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | ($21.71M) | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | ($21.30M) | Jul 28, 2023 |
| FY2022 | Apr 30, 2021 | ($11.67M) | Jul 13, 2022 |
| FY2021 | Apr 30, 2020 | ($10.58M) | Jul 19, 2021 |
| FY2020 | Apr 30, 2019 | ($12.14M) | Jun 29, 2020 |
| FY2019 | Apr 30, 2018 | ($10.70M) | Jul 22, 2019 |
| FY2018 | Apr 30, 2017 | ($10.04M) | Jul 17, 2018 |
| FY2017 | Apr 30, 2016 | ($10.93M) | Jul 14, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $505.0K | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $2.59M | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | $648.0K | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | $145.0K | Jul 28, 2023 |
| FY2022 | Apr 30, 2021 | $26.0K | Jul 13, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $30.79M | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $28.70M | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | $53.37M | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | $73.39M | Jul 28, 2023 |
| FY2022 | Apr 30, 2021 | $86.38M | Jul 13, 2022 |
| FY2021 | Apr 30, 2020 | $13.54M | Jul 19, 2021 |
| FY2020 | Apr 30, 2019 | $18.37M | Jun 29, 2020 |
| FY2019 | Apr 30, 2018 | $14.12M | Jul 22, 2019 |
| FY2018 | Apr 30, 2017 | $10.07M | Jul 17, 2018 |
| FY2017 | Apr 30, 2016 | $10.35M | Jul 14, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $4.14M | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $9.36M | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | $9.42M | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | $4.56M | Jul 28, 2023 |
| FY2022 | Apr 30, 2021 | $5.91M | Jul 13, 2022 |
| FY2021 | Apr 30, 2020 | $3.05M | Jul 19, 2021 |
| FY2020 | Apr 30, 2019 | $2.59M | Jun 29, 2020 |
| FY2019 | Apr 30, 2018 | $3.89M | Jul 22, 2019 |
| FY2018 | Apr 30, 2017 | $4.63M | Jul 17, 2018 |
| FY2017 | Apr 30, 2016 | $6.82M | Jul 14, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $26.65M | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $19.34M | Jul 24, 2025 |
| FY2025 | Apr 30, 2023 | $43.95M | Jul 24, 2025 |
| FY2024 | Apr 30, 2022 | $68.83M | Jul 25, 2024 |
| FY2023 | Apr 30, 2021 | $80.47M | Jul 28, 2023 |
| FY2022 | Apr 30, 2020 | $10.49M | Jul 13, 2022 |
| FY2021 | Apr 30, 2019 | $15.78M | Jul 19, 2021 |
| FY2020 | Apr 30, 2018 | $10.24M | Jun 29, 2020 |
| FY2019 | Apr 30, 2017 | $5.45M | Jul 22, 2019 |
| FY2018 | Apr 30, 2016 | $3.53M | Jul 17, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $8.54M | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $8.54M | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | $8.54M | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | $8.54M | Jul 28, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($329.09M) | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | ($307.58M) | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | ($280.10M) | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | ($253.77M) | Jul 28, 2023 |
| FY2022 | Apr 30, 2021 | ($234.90M) | Jul 13, 2022 |
| FY2021 | Apr 30, 2020 | ($220.14M) | Jul 19, 2021 |
| FY2020 | Apr 30, 2019 | ($209.78M) | Jun 29, 2020 |
| FY2019 | Apr 30, 2018 | ($197.54M) | Jul 22, 2019 |
| FY2018 | Apr 30, 2017 | ($187.37M) | Jul 17, 2018 |
| FY2017 | Apr 30, 2016 | ($177.88M) | Jul 14, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $6.72M | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $3.15M | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | $6.88M | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | $7.89M | Jul 28, 2023 |
| FY2022 | Apr 30, 2021 | $83.03M | Jul 13, 2022 |
| FY2021 | Apr 30, 2020 | $10.00M | Jul 19, 2021 |
| FY2020 | Apr 30, 2019 | $16.66M | Jun 29, 2020 |
| FY2019 | Apr 30, 2018 | $11.50M | Jul 22, 2019 |
| FY2018 | Apr 30, 2017 | $8.42M | Jul 17, 2018 |
| FY2017 | Apr 30, 2016 | $6.73M | Jul 14, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Apr 30, 2016 | $50.0K | Jul 15, 2016 |
| FY2016 | Apr 30, 2015 | $150.0K | Jul 15, 2016 |
| FY2015 | Apr 30, 2014 | $250.0K | Jul 6, 2015 |
| FY2014 | Apr 30, 2013 | $350.0K | Jul 29, 2014 |
| FY2013 | Apr 30, 2012 | $450.0K | Jul 12, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 0 | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | 0 | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | 0 | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | 0 | Jul 28, 2023 |
| FY2022 | Apr 30, 2021 | 0 | Jul 13, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 0 | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | 0 | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | 0 | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | 0 | Jul 28, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 171.26M | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | 61.26M | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | 56.26M | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | 55.88M | Jul 28, 2023 |
| FY2022 | Apr 30, 2021 | 52.48M | Jul 13, 2022 |
| FY2021 | Apr 30, 2020 | 12.94M | Jul 19, 2021 |